“Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s39. https://doi.org/10.25251/skin.4.supp.39.